Papers

6

Total Citations

60

H-Index

4

About

Dr. Debnarayan Dutta is a leading radiation oncologist whose research centers on stereotactic radiosurgery (SRS) and robotic radiosurgery, with a particular focus on treating complex liver and brain tumors. His most impactful work includes a landmark dosimetric comparison of Linac-based (BrainLAB®) and robotic (CyberKnife®) systems for acoustic schwannoma, which has garnered 31 citations and remains a key reference for treatment planning. Dr. Dutta has made significant contributions to the management of hepatocellular carcinoma (HCC), especially in patients with portal vein thrombosis—a historically challenging condition. His prospective study on robotic radiosurgery for this cohort (15 citations) demonstrated promising interim outcomes, while his early experience with CyberKnife for liver tumors (6 citations) established a foundation for non-invasive liver cancer treatment in India. More recently, he has prospectively evaluated SRS-only treatment for oligo-brain metastasis in Indian patients, addressing a critical gap in regional data. Dr. Dutta’s work on re-irradiation of liver metastases and the correlation of portal vein tumor thrombus response with survival further underscores his dedication to advancing radiosurgical techniques for high-risk, recurrent cancers. His cumulative research has shaped clinical protocols and improved outcomes for patients with limited treatment options.

Research Focus

Key Achievements

4
H-Index
6
Papers
60
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife®) stereotactic system plans for acoustic schwannoma
31 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Apollo Hospitals, Amrita Institute of Medical Sciences and Research Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago